Gentronix (United Kingdom)

M13 9NT (North West)

Start Date

End Date Funded Value Relevance

CSV

25 50 100

£289,962

May 06 - May 08

Understanding the biology behind a new and potentially valuable mammalian cell assay for chromosome breakage mutation and mis-segregation.

BBSRC award to Gentronix (United Kingdom) and Richard Walmsley

{{facetGroup.name}}

{{getFilterText(facet,showCount)}}